Localization of IL-8 and complement components in lesional skin of psoriasis vulgaris and pustulosis palmaris et plantaris

Dermatology

Volumn 211, Issue 3, 2005, Pages 249-255

  Ozawa, Maki ^a   Terui, Tadashi ^a   Tagami, Hachiro ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

C3; C5; Chemotactic factor; Immunohistochemistry; Neutrophil

Indexed keywords

COMPLEMENT COMPONENT C5A; INTERLEUKIN 8;

ARTICLE; CELL MEMBRANE; CELL MIGRATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PSORIASIS VULGARIS; PUSTULOSIS PALMOPLANTARIS; SKIN DEFECT;

CELL MOVEMENT; CHEMOTACTIC FACTORS; COMPLEMENT C5A; HUMANS; INTERLEUKIN-8; KERATINOCYTES; NEUTROPHILS; PSORIASIS; SKIN;

EID: 26244437540     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087019     Document Type: Article

References (31)

1. Christophers E, Schroder JM, Mrowietz U: Identification of two endogenous neutrophil-activating peptides in psoriatic skin and inflammatory cells: C5ades arg and NAP. Dermatologica 1989;179(suppl 1):9-15.
2. Dahl MV, Lindroos WE, Nelson RD: Chemokinetic and chemotactic factors in psoriasis scale extracts. J Invest Dermatol 1978;71:402-406.
3. Bergh K, Iversen OJ, Lysvand H: Surprisingly high levels of anaphylatoxin C5a des Arg are extractable from psoriatic scales. Arch Dermatol Res 1993;285:131-134.
4. Kulke R, Todt-Pingel I, Rademacher D, Rowert J, Schroder JM, Christophers E: Co-localized overexpression of GRO-alpha and IL-8 mRNA is restricted to the suprapapillary layers of psoriatic lesions. J Invest Dermatol 1996;106:526-530.
5. Gillitzer R, Ritter U, Spandau U, Goebeler M, Brocker EB: Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: A model for neutrophil migration and accumulation in vivo. J Invest Dermatol 1996;107:778-782.
6. Sticherling M, Bornscheuer E, Schroder JM, Christophers E: Localization of neutrophil-activating peptide-1/interleukin-8-immunoreactivity in normal and psoriatic skin. J Invest Dermatol 1991;96:26-30.
7. Sticherling M, Sautier W, Schroder JM, Christophers E: Interleukin-8 plays its role at local level in psoriasis vulgaris. Acta Derm Venereol 1999;79:4-8.
8. Anttila HS, Reitamo S, Erkko P, Ceska M, Moser B, Baggiolini M: Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. J Invest Dermatol 1992;98:96-101.
9. Duan H, Koga T, Kohda F, Kara H, Urabe K, Furue M: Interleukin-8-positive neutrophils in psoriasis. J Dermatol Sci 2001;26:119-124.
10. Sticherling M, Bornscheuer E, Schroder JM, Christophers E: Immunohistochemical studies on NAP-1/IL-8 in contact eczema and atopic dermatitis. Arch Dermatol Res 1992;284:82-85.
11. Takematsu H, Tagami H: Quantification of chemotactic peptides (C5a anaphylatoxin and IL-8) in psoriatic lesional skin. Arch Dermatol 1993;129:74-80.
12. Foxman EF, Kunkel EJ, Butcher EC: Integrating conflicting chemotactic signals. The role of memory in leukocyte navigation. J Cell Biol 1999;147:577-588.
13. Terui T, Kato T, Tagami H: Stratum corneum activation of complement through the antibody-independent alternative pathway. J Invest Dermatol 1989;92:593-597.
14. Nickoloff BJ, Karabin GD, Barker JN, et al: Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 1991;138:129-140.
15. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ: Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 1994;144:820-828.
16. Jiang WY, Chattedee AD, Raychaudhuri SP, Raychaudhuri SK, Farber EM: Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Int J Dermatol 2001;40:699-703.
17. Bruch-Gerharz D, Fehsel K, Suschek C, Michel G, Ruzicka T, Kolb-Bachofen V: A proinflammatory activity of interleukin 8 in human skin: Expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med 1996;184:2007-2012.
18. Piskin G, Tursen U, Bos JD, Teunissen MB: IL-4 expression by neutrophils in psoriasis lesional skin upon high-dose UVB exposure. Dermatology 2003;207:51-53.
19. Tagami H, Ofuji S: A leukotactic factor in the stratum corneum of pustulosis palmaris et plantaris: A possible mechanism for the formation of intra-epidermal sterile pustules. Acta Derm Venereol 1978;58:401-405.
20. Schroder JM, Christophers E: Identification of C5ades arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 1986;87:53-58.
21. Takematsu H, Terui T, Ohkohchi K, Tagami H, Suzuki R, Kumagai K: Presence of chemotactic peptides other than C5a anaphylatoxin in scales of psoriasis and sterile pustular dermatoses. Acta Derm Venereol 1986;66:93-97.
22. Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA, Bos JD: Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 1998;111:645-649.
23. Ohta Y, Hamada Y: In situ expression of CD40 and CD40 ligand in psoriasis. Dermatology 2004;209:21-28.
24. Gillitzer R, Berger R, Mielke V, Muller C, Wolff K, Stingl G: Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol 1991;97:73-79.
25. Barker JN, Griffiths CE, Nickoloff BJ: NAP-1/IL-8 immunoreactivity in normal and psoriatic skin. J Invest Dermatol 1991;97:606-608.
26. Sayama K, Shiraishi S, Shirakata Y, Kobayashi Y, Seya T, Miki Y: Expression and characterization of membrane co-factor protein (MCP) in human skin. J Invest Dermatol 1991;97:722-724.
27. Sayama K, Shiraishi S, Shirakata Y, Kobayashi Y, Miki Y: Characterization of decay-accelerating factor (DAF) in human skin. J Invest Dermatol 1991;96:61-64.
28. Terui T, Zhen YX, Kato T, Tagami H: Mechanism of human polymorphonuclear leukocyte adhesion to serum-treated corneocytes. J Invest Dermatol 1995;104:297-301.
29. Ozawa M, Terui T, Tanita M, Kato T, Tagami H: Release of monocyte chemoattractants by polymorphonuclear leukocytes stimulated by their adhesion to stratum corneum opsonized via complement activation, measured with a human acute monocytic leukemic cell line, THP-1. Exp Dermatol 1998;7:151-156.
30. Terui T, Ishii K, Ozawa M, Tabata N, Kato T, Tagami H: C3 production of cultured human epidermal keratinocytes is enhanced by IFN-gamma and TNFalpha through different pathways. J Invest Dermatol 1997;108:62-67.
31. Pasch MC, Van Den Bosch NH, Daha MR, Bos JD, Asghar SS: Synthesis of complement components C3 and factor B in human keratinocytes is differentially regulated by cytokines. J Invest Dermatol 2000;114:78-82.